YAZICI, O. Et Al. 2015. Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer. 2015 ASCO Annual Meeting .

YAZICI, O., AKSOY, S., ŞENDUR, M. A. N., ÖZDEMİR, N., Akinci, M. B., ZENGİN, N., ... ALTUNDAĞ, M. K.(2015). Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer . 2015 ASCO Annual Meeting

YAZICI, OZAN Et Al. "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer," 2015 ASCO Annual Meeting, 2015

YAZICI, OZAN Et Al. "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer." 2015 ASCO Annual Meeting , 2015

YAZICI, O. Et Al. (2015) . "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer." 2015 ASCO Annual Meeting .

@conferencepaper{conferencepaper, author={OZAN YAZICI Et Al. }, title={Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer}, congress name={2015 ASCO Annual Meeting}, city={}, country={}, year={2015}}